查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
免疫组库定序市场（按产品、技术、工作流程、应用、最终用户和地区划分）—预测至 2030 年
市场调查报告书
商品编码
1714900

免疫组库定序市场（按产品、技术、工作流程、应用、最终用户和地区划分）—预测至 2030 年

Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 371 Pages | 订单完成后即时交付

价格

全球免疫组库定序(IRS) 市场规模预计将从 2025 年的 3.34 亿美元增至 2030 年的 5.65 亿美元，预测期内的复合年增长率为 9.6%。

随着技术进步提高了基于免疫测量的研究解决方案的效率、灵敏度和可扩展性，这个市场正在不断扩大。 NGS 整合、自动化液体处理系统和高通量筛检平台等技术创新正在实现更快、更准确的检测结果。这些进步简化了工作流程，减少了人工错误并提高了吞吐量，使 IRS 技术更易于研究和临床应用，并且更可靠。此外，随着对个人化和精准医疗的关注度不断提高，医疗保健提供者和研究人员越来越需要检测特定生物标记并针对个别患者量身定制治疗方案的工具，从而推动对 IRS 解决方案的需求。这种向标靶治疗的转变将推动旨在支持伴同性诊断、治疗监测和个人化治疗策略的特定检测套件和试剂的开发。因此，人们越来越需要能够提供准确、以患者为中心的资料指南临床决策和改善结果的免疫测量技术。

研究范围
调查年份 2024-2030
基准年 2024
预测期 2024-2030
对价单位 金额（百万美元）
部分 按产品、技术、工作流程、应用程式、最终用户、地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

在预测期内，定序技术领域占据免疫组库定序产品市场的最大份额。

2024年，定序技术占据IRS产品市场按技术分類的最大市场份额。定序技术是免疫组库定序研究的核心。 NGS 技术的进步提高了读取长度、吞吐量和周转时间，同时大幅降低了每次运行的成本，使定序在临床和研究环境中更具可扩展性和可访问性。此外，主要企业在平台技术方面的不断创新，实现了高效、易于使用的测序仪的商业化，支持广泛的应用，包括免疫肿瘤学、感染疾病分析和疫苗开发。这一核心作用，加上学术和商业研究环境中的高采用率，使得定序技术成为最大的 IRS 产品市场。

在预测期内，学术研究机构在免疫组库定序产品市场中占据最终用户最大的市场占有率。

学术研究机构是 IRS 产品的最大最终用户，包括检测试剂套件、试剂、仪器和软体。许多探索性和假设驱动的研究，包括免疫分析、生物标记发现和疾病机制阐明，正在严重依赖 IRS 技术的大学和学术医疗中心进行。学术机构对检测试剂套件、试剂、定序设备和生物资讯软体的需求达到了前所未有的高度，因为各种研究计画都需要灵活、可扩展且精确的工具。此外，政府和研究机构对免疫学、肿瘤学和感染疾病研究的资金增加，推动了 IRS 技术在学术机构的广泛应用。

预计在研究期间，亚太地区将成为免疫组定序市场成长最快的地区。

预计亚太地区的 IRS 市场将在预测期内实现最高成长率。这种高成长归因于对医疗保健基础设施建设的重视程度不断提高以及对生物医学研究的投资不断增加。中国、印度、韩国和日本等国的政府正在拨出大量资金支持包括 IRS 在内的生命科学和精准医疗工作。此外，由于人口多样化和营运成本低而具有巨大的成长潜力，主要区域公司增加投资也是支持该地区在预测期内快速成长的关键因素。

本报告研究了全球免疫组库定序市场，并从产品、技术、工作流程、应用、最终用户、区域趋势和公司概况等方面对市场进行了详细分析。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章市场概述

  • 介绍
  • 市场动态
  • 影响客户业务的趋势/中断
  • 定价分析
  • 供应链分析
  • 价值链分析
  • 生态系分析
  • 技术分析
  • 专利分析
  • 贸易资料分析
  • 2025-2026 年重要会议与活动
  • 监管分析
  • 波特五力分析
  • 主要相关人员和采购标准
  • 投资金筹措场景
  • 人工智慧/生成式人工智慧对免疫组库定序市场的影响

6. 免疫组库定序市场（依产品）

  • 介绍
  • 检测套件和试剂
  • 设备和软体

7. 免疫组库定序产品市场（依技术）

  • 介绍
  • 定序技术
  • 图书馆创建技术
  • 生物资讯学和资料分析技术

8. 免疫组库定序服务市场（依工作流程）

  • 介绍
  • 定序服务
  • 资料分析服务
  • 定序服务

9. 免疫组库定序市场（依应用）

  • 介绍
  • 研究
  • 药物研发
  • 临床诊断

第 10 章。免疫组库定序产品市场（依最终用户）

  • 介绍
  • 学术研究所
  • 製药和生物技术公司
  • 其他的

第 11 章免疫组库定序服务市场（依最终用户）

  • 介绍
  • 製药和生物技术公司
  • 学术研究所
  • 其他的

12. 免疫组库定序市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东
    • 中东宏观经济展望
    • 海湾合作委员会国家
    • 其他的
  • 非洲
    • 政府资金增加及扩大国际伙伴关係推动市场成长
    • 非洲宏观经济展望

第十三章竞争格局

  • 介绍
  • 主要参与企业的策略/优势，2022-2025
  • 2022-2024年收益分析
  • 2024年市场占有率分析
  • 估值和财务指标
  • 品牌/产品比较
  • 公司估值矩阵：2024 年主要参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 竞争场景

第十四章 公司简介

  • 主要参与企业
    • ILLUMINA, INC.
    • THERMO FISHER SCIENTIFIC INC.
    • PACBIO
    • OXFORD NANOPORE TECHNOLOGIES PLC
    • 10X GENOMICS
    • QIAGEN
    • AGILENT TECHNOLOGIES
    • DANAHER CORPORATION
    • TAKARA BIO INC.
    • ADAPTIVE BIOTECHNOLOGIES
    • BGI GROUP
    • TECAN TRADING AG
    • AZENTA US INC.
    • PERSONALIS, INC.
    • CREATIVE BIOLABS
  • 其他公司
    • CELEMICS, INC.
    • CELLCARTA
    • IREPERTOIRE, INC.
    • NEW ENGLAND BIOLABS
    • CERBA RESEARCH
    • CEGAT GMBH
    • ELEMENT BIOSCIENCES
    • SEQALIS
    • SYNBIO TECHNOLOGIES
    • MEDGENOME
    • ENPICOM

第十五章 附录

Product Code: BT 9352

The global IRS market is projected to reach USD 565 million in 2030 from USD 334 million in 2025, growing at a CAGR of 9.6% during the forecast period. This market is growing as increased technological advancements continue to enhance the efficiency, sensitivity, and scalability of immunoassay-based research solutions. Innovations such as NGS integration, automated liquid handling systems, and high-throughput screening platforms enable faster and more accurate assay results. These advancements streamline workflows, reduce manual errors, and increase throughput, making IRS technologies more accessible and reliable for research and clinical applications. Moreover, the growing focus on personalized and precision medicine drives the demand for IRS solutions, as healthcare providers and researchers increasingly require tools that detect specific biomarkers and tailor treatments to individual patients. This shift toward targeted therapies fosters the development of particular assay kits & reagents designed to support companion diagnostics, therapeutic monitoring, and individualized treatment strategies. As a result, there is a rising need for immunoassay technologies that can deliver accurate, patient-centric data to guide clinical decisions and improve outcomes.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD million)
SegmentsProduct (Technology, End User), Service (Workflow, End User), Application
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East, and Africa

The sequencing technology segment held the largest share in the immune repertoire sequencing products market, by technology, during the forecast period.

In 2024, sequencing technology held the largest market within the IRS products market by technology. Sequencing technologies are the core enablers of immune repertoire sequencing studies. Advances in NGS technologies have significantly lowered the cost per run while improving read lengths, throughput, and turnaround time-making sequencing more scalable and accessible across clinical and research settings. Moreover, the continuous innovation in platform technologies by key industry players has led to the commercialization of highly efficient, user-friendly sequencers that support a broad array of applications, including immuno-oncology, infectious disease profiling, and vaccine development. Thus, this central role, coupled with high adoption rates in both academic and commercial research environments, positions sequencing technology as the largest in the IRS product market.

Academic & research institutes held the largest market share in the immune repertoire sequencing products market, by end user, during the forecast period.

Academic & research institutes are the largest end users of IRS products, such as assay kits & reagents, instruments, and software. Universities and academic medical centers conduct many exploratory and hypothesis-driven studies that rely heavily on IRS technologies for immune profiling, biomarker discovery, and understanding disease mechanisms. The demand for assay kits, reagents, sequencing instruments, and bioinformatics software is consistently high in academia, where diverse research programs require flexible, scalable, and precise tools. Moreover, increased government and institutional funding for immunology, oncology, and infectious disease research further supports the widespread adoption of IRS technologies in academic settings.

The Asia Pacific is expected to be the fastest growing region in the immune repertoire sequencing market during the study period.

The Asia Pacific IRS market is projected to register the highest growth rate during the forecast period. This high growth is attributed to the growing emphasis on healthcare infrastructure development and increased investments in biomedical research. Governments across countries such as China, India, South Korea, and Japan allocate substantial funding to support life sciences and precision medicine initiatives, including the IRS. Additionally, increasing investments of key regional players, considering the enormous growth potential mainly due to the diverse population and low operational costs, is another key factor supporting the region's fastest growth during the forecast period.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1-44%, Tier 2-32%, and Tier 3-24%
  • By Designation: (Managers)-45%, (CXOs, Directors)-30%, and (Executives)-25%
  • By Region: North America-40%, Europe-25%, Asia-Pacific-20%, Rest of the World-15%

List of Companies Profiled in the Report:

  • Illumina, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • PacBio (US)
  • Oxford Nanopore Technologies PLC (UK)
  • 10X Genomics (US)
  • QIAGEN (Netherlands)
  • Agilent Technologies (US)
  • Danaher Corporation (US)
  • Takara Bio Inc. (Japan)
  • Adaptive Biotechnologies (US)
  • BGI Group (China)
  • Tecan Trading AG (Switzerland)
  • Azenta US Inc. (US)
  • Personalis, Inc. (US)
  • Creative Biolabs (US)
  • Celemics, Inc. (South Korea)
  • CellCarta (Canada)
  • iRepertoire, Inc. (US)
  • New England Biolabs (US)
  • Cerba Research (Belgium)
  • CeGat GmbH (Germany)
  • Element Biosciences (US)
  • Seqalis (Belgium)
  • Synbio Technologies (China)
  • MedGenome (US)
  • Enpicom (Netherlands)

Research Coverage:

This report provides a detailed picture of the global IRS market. It aims to estimate the market's size and future growth potential across different segments such as the product, service, application product-technology, product-end user, service-end user, and region. The report's scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the IRS market. A thorough analysis of the key industry players has provided insights into their business overview, solutions, services, key strategies, partnerships, agreements, new product and service launches, mergers and acquisitions, and recent developments associated with the immune repertoire sequencing market. This report covers the competitive analysis of upcoming startups in the immune repertoire sequencing market ecosystem.

Reasons to Buy this Report :

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall immune repertoire sequencing market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing technological advancements, growing focus on precision/personalized medicines, increasing use of IRS in organ transplantation), restraints (need for high capital investments), opportunities (integration of AI and ML in IRS), and challenges (variations in regulatory frameworks and international trade dynamics) influencing the growth of the immune repertoire sequencing market.
  • Product/ Service Development/Innovation: Detailed insights on upcoming technologies and new product and service launches in the immune repertoire sequencing market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the immune repertoire sequencing market across varied regions.
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the immune repertoire sequencing market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product and service offerings of leading players in the immune repertoire sequencing market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key objectives of secondary research
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of primaries
      • 2.1.2.2 Key objectives of primary research
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 GLOBAL MARKET ESTIMATION
      • 2.2.1.1 Bottom-up approach
      • 2.2.1.2 Insights from primary experts
    • 2.2.2 SEGMENTAL MARKET ESTIMATION (TOP-DOWN APPROACH)
  • 2.3 MARKET GROWTH RATE PROJECTION
  • 2.4 DATA TRIANGULATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 IMMUNE REPERTOIRE SEQUENCING MARKET OVERVIEW
  • 4.2 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT AND COUNTRY
  • 4.3 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET SHARE, BY TECHNOLOGY, 2025 VS. 2030
  • 4.4 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET SHARE, BY END USER, 2025
  • 4.5 IMMUNE REPERTOIRE SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing technological advancements
      • 5.2.1.2 Growing focus on personalized/precision medicines
      • 5.2.1.3 Increasing use of immune repertoire sequencing in organ transplant monitoring
      • 5.2.1.4 Increasing applications in autoimmune disease research
      • 5.2.1.5 Rising focus on cancer immunotherapy research
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Need for high capital investments
      • 5.2.2.2 Limited clinical adoption and validation
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Integration of AI and ML into immune repertoire sequencing
      • 5.2.3.2 Increasing applications in vaccine development
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Variations in regulatory frameworks and international trade dynamics
      • 5.2.4.2 Lack of workflow and data standardization
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE TREND OF IMMUNE REPERTOIRE SEQUENCING PRODUCTS, BY KEY PLAYER, 2022-2024
    • 5.4.2 AVERAGE SELLING PRICE OF IMMUNE REPERTOIRE SEQUENCING INSTRUMENTS, BY REGION, 2024
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • 5.7.1 ROLE IN ECOSYSTEM
      • 5.7.1.1 Product providers
      • 5.7.1.2 Service providers
      • 5.7.1.3 End users
      • 5.7.1.4 Regulatory bodies
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES
      • 5.8.1.1 High-throughput sequencing
      • 5.8.1.2 Nanopore sequencing
      • 5.8.1.3 Single-molecule real-time (SMRT) sequencing
    • 5.8.2 COMPLEMENTARY TECHNOLOGIES
      • 5.8.2.1 Bioinformatics and data analysis platforms
      • 5.8.2.2 Multiplex PCR
      • 5.8.2.3 5'RACE
    • 5.8.3 ADJACENT TECHNOLOGIES
      • 5.8.3.1 Multi-omics integration
      • 5.8.3.2 Spatial genomics and transcriptomics
      • 5.8.3.3 Single-cell sequencing technologies
  • 5.9 PATENT ANALYSIS
  • 5.10 TRADE DATA ANALYSIS
    • 5.10.1 IMPORT DATA FOR HS CODE 3822, 2020-2024
    • 5.10.2 EXPORT DATA FOR HS CODE 3822, 2020-2024
  • 5.11 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.12 REGULATORY ANALYSIS
    • 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.12.2 REGULATORY FRAMEWORK
      • 5.12.2.1 North America
        • 5.12.2.1.1 US
        • 5.12.2.1.2 Canada
      • 5.12.2.2 Europe
        • 5.12.2.2.1 UK
      • 5.12.2.3 Asia Pacific
        • 5.12.2.3.1 China
        • 5.12.2.3.2 Japan
        • 5.12.2.3.3 South Korea
        • 5.12.2.3.4 Australia
        • 5.12.2.3.5 India
        • 5.12.2.3.6 Rest of Asia Pacific
  • 5.13 PORTER'S FIVE FORCES ANALYSIS
    • 5.13.1 THREAT OF NEW ENTRANTS
    • 5.13.2 THREAT OF SUBSTITUTES
    • 5.13.3 BARGAINING POWER OF BUYERS
    • 5.13.4 BARGAINING POWER OF SUPPLIERS
    • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.14.2 KEY BUYING CRITERIA
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 IMPACT OF AI/GEN AI ON IMMUNE REPERTOIRE SEQUENCING MARKET

6 IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 ASSAY KITS & REAGENTS
    • 6.2.1 TCR KITS
      • 6.2.1.1 Human TCR kits
        • 6.2.1.1.1 Increased demand for high-throughput TCR profiling in oncology and immunotherapy research to fuel market growth
      • 6.2.1.2 Mouse TCR kits
        • 6.2.1.2.1 Rising demand for TCR profiling in preclinical studies and growing need for standardized workflows to drive segment
    • 6.2.2 BCR KITS
      • 6.2.2.1 Human BCR kits
        • 6.2.2.1.1 Increasing demand for high-throughput profiling and rising focus on immunology research to fuel uptake
      • 6.2.2.2 Mouse BCR kits
        • 6.2.2.2.1 High demand for antibody discovery and preclinical research to boost segment growth
    • 6.2.3 OTHER ASSAY KITS & REAGENTS
  • 6.3 INSTRUMENTS & SOFTWARE
    • 6.3.1 TECHNOLOGICAL ADVANCEMENTS IN TRANSLATIONAL RESEARCH AND COMPANION DIAGNOSTICS TO AUGMENT MARKET GROWTH

7 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 SEQUENCING TECHNOLOGIES
    • 7.2.1 BULK SEQUENCING (MULTI-CELL SEQUENCING) TECHNOLOGIES
      • 7.2.1.1 Increasing adoption of TCR sequencing for inflammation-mediated diseases to support segment growth
    • 7.2.2 SINGLE-CELL SEQUENCING TECHNOLOGIES
      • 7.2.2.1 Need for integrative analysis of immune receptor repertoires and transcriptional states to spur market growth
  • 7.3 LIBRARY PREPARATION TECHNOLOGIES
    • 7.3.1 HIGH DEMAND FOR COST-EFFICIENT AND HIGH-THROUGHPUT IMMUNE REPERTOIRE PROFILING TO FUEL MARKET GROWTH
  • 7.4 BIOINFORMATICS & DATA ANALYSIS TECHNOLOGIES
    • 7.4.1 GROWING FOCUS ON RESEARCH TO DRIVE DEMAND FOR ADVANCED BIOINFORMATICS & DATA ANALYSIS TECHNOLOGIES

8 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW

  • 8.1 INTRODUCTION
  • 8.2 SEQUENCING SERVICES
    • 8.2.1 RISING NEED FOR HIGH-RESOLUTION IMMUNE PROFILING IN CANCER AND AUTOIMMUNE DISEASES TO DRIVE MARKET
  • 8.3 DATA ANALYSIS SERVICES
    • 8.3.1 HIGH DEMAND FOR STANDARDIZED NGS DATA INTERPRETATION AND CROSS-SAMPLE COMPARABILITY TO DRIVE MARKET
  • 8.4 PRE-SEQUENCING SERVICES
    • 8.4.1 INCREASED REQUIREMENT FOR STANDARDIZED WORKFLOWS FOR ADDRESSING PCR BIAS TO AUGMENT MARKET GROWTH

9 IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 RESEARCH APPLICATIONS
    • 9.2.1 LOW SEQUENCING COSTS AND INCREASED NEED TO RESOLVE CELLULAR HETEROGENEITY AT HIGH RESOLUTION TO DRIVE MARKET
  • 9.3 DRUG DISCOVERY & DEVELOPMENT
    • 9.3.1 INCREASED NEED FOR TARGETED THERAPIES AND ADVANCEMENTS IN HIGH-THROUGHPUT SCREENING TO AID MARKET GROWTH
  • 9.4 CLINICAL DIAGNOSTICS
    • 9.4.1 GROWING DEMAND FOR EARLY DETECTION OF SUBCLINICAL CONDITIONS TO AID MARKET GROWTH

10 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 ACADEMIC & RESEARCH INSTITUTES
    • 10.2.1 INCREASED FUNDING FOR IMMUNOLOGICAL RESEARCH AND IMMUNOGENOMICS TO DRIVE MARKET
  • 10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.3.1 RISING FOCUS ON DRUG DISCOVERY AND THERAPEUTIC DEVELOPMENT TO SUPPORT MARKET GROWTH
  • 10.4 OTHER END USERS

11 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 11.2.1 NEED TO REDUCE IN-HOUSE INFRASTRUCTURE COSTS AND MEET SCALABILITY DEMANDS TO BOOST MARKET GROWTH
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
    • 11.3.1 INCREASING FUNDING FOR GENOMIC RESEARCH AND GROWING DEMAND FOR COMPLEX DATA ANALYSIS TO AID MARKET GROWTH
  • 11.4 OTHER END USERS

12 IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 US to dominate North American market during forecast period
    • 12.2.3 CANADA
      • 12.2.3.1 Presence of advanced research facilities and favorable government-funded genomic studies to spur market growth
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 GERMANY
      • 12.3.2.1 Technological advancements in RNA sequencing to fuel market growth
    • 12.3.3 UK
      • 12.3.3.1 Increased cross-sector partnerships and advancements in AI tools for large sequencing datasets to boost market growth
    • 12.3.4 FRANCE
      • 12.3.4.1 Public-private collaborations and increased funding for advanced genomic infrastructure to aid market growth
    • 12.3.5 ITALY
      • 12.3.5.1 High investments in genomic research to drive market
    • 12.3.6 SPAIN
      • 12.3.6.1 Increased government investments in precision medicine, genomic medicine, and data science to propel market growth
    • 12.3.7 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 CHINA
      • 12.4.2.1 Rising incidence of chronic diseases and increasing collaborations among industry stakeholders to drive market
    • 12.4.3 JAPAN
      • 12.4.3.1 Increasing research on long-read and biomolecular sequencing to aid market growth
    • 12.4.4 INDIA
      • 12.4.4.1 Advancements in genomic research and focus on industry-academia collaborations to expedite market growth
    • 12.4.5 SOUTH KOREA
      • 12.4.5.1 Favorable government initiatives and investment in sequencing technologies to boost market growth
    • 12.4.6 AUSTRALIA
      • 12.4.6.1 Increased research funding and favorable government initiatives to drive market
    • 12.4.7 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 BRAZIL
      • 12.5.2.1 Supportive regulatory framework for biotechnology innovation to fuel market growth
    • 12.5.3 MEXICO
      • 12.5.3.1 High geriatric population and advancements in precision medicine research to support market growth
    • 12.5.4 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    • 12.6.2 GCC COUNTRIES
      • 12.6.2.1 Favorable government initiatives to drive drug development and clinical research
    • 12.6.3 REST OF MIDDLE EAST
  • 12.7 AFRICA
    • 12.7.1 RISING GOVERNMENT FUNDING AND INCREASING INTERNATIONAL PARTNERSHIPS TO FAVOR MARKET GROWTH
    • 12.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
  • 13.3 REVENUE ANALYSIS, 2022-2024
  • 13.4 MARKET SHARE ANALYSIS, 2024
  • 13.5 COMPANY VALUATION & FINANCIAL METRICS
    • 13.5.1 COMPANY VALUATION
    • 13.5.2 FINANCIAL METRICS
  • 13.6 BRAND/PRODUCT COMPARISON
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 PARTICIPANTS
    • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 13.7.5.1 Company footprint
      • 13.7.5.2 Region footprint
      • 13.7.5.3 Product and service footprint
      • 13.7.5.4 Application footprint
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 RESPONSIVE COMPANIES
    • 13.8.3 DYNAMIC COMPANIES
    • 13.8.4 STARTING BLOCKS
    • 13.8.5 COMPETITIVE BENCHMARKING
      • 13.8.5.1 Detailed list of key startups/SMEs
      • 13.8.5.2 Competitive benchmarking of key startups/SMEs
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES/APPROVALS/UPGRADES
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 ILLUMINA, INC.
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Services/Solutions offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Product launches/approvals/upgrades
        • 14.1.1.3.2 Deals
        • 14.1.1.3.3 Expansions
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Key strengths
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses & competitive threats
    • 14.1.2 THERMO FISHER SCIENTIFIC INC.
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products/Services/Solutions offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Product launches/approvals/upgrades
        • 14.1.2.3.2 Deals
        • 14.1.2.3.3 Expansions
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Key strengths
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses & competitive threats
    • 14.1.3 PACBIO
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Services/Solutions offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product launches/approvals/upgrades
        • 14.1.3.3.2 Deals
        • 14.1.3.3.3 Expansions
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses & competitive threats
    • 14.1.4 OXFORD NANOPORE TECHNOLOGIES PLC
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products/Services/Solutions offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Product launches/approvals/upgrades
        • 14.1.4.3.2 Deals
      • 14.1.4.4 MnM view
        • 14.1.4.4.1 Key strengths
        • 14.1.4.4.2 Strategic choices
        • 14.1.4.4.3 Weaknesses & competitive threats
    • 14.1.5 10X GENOMICS
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products/Services/Solutions offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Product launches/approvals/upgrades
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Key strengths
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses & competitive threats
    • 14.1.6 QIAGEN
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products/Services/Solutions offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Product launches/approvals/upgrades
        • 14.1.6.3.2 Deals
        • 14.1.6.3.3 Expansions
    • 14.1.7 AGILENT TECHNOLOGIES
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Services/Solutions offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Deals
        • 14.1.7.3.2 Expansions
    • 14.1.8 DANAHER CORPORATION
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products/Services/Solutions offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Deals
    • 14.1.9 TAKARA BIO INC.
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products/Services/Solutions offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Deals
    • 14.1.10 ADAPTIVE BIOTECHNOLOGIES
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products/Services/Solutions offered
    • 14.1.11 BGI GROUP
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products/Services/Solutions offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Product launches/approvals/upgrades
        • 14.1.11.3.2 Deals
        • 14.1.11.3.3 Other developments
    • 14.1.12 TECAN TRADING AG
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products/Services/Solutions offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Deals
    • 14.1.13 AZENTA US INC.
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products/Services/Solutions offered
    • 14.1.14 PERSONALIS, INC.
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products/Services/Solutions offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Deals
        • 14.1.14.3.2 Other developments
    • 14.1.15 CREATIVE BIOLABS
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products/Services/Solutions offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 CELEMICS, INC.
    • 14.2.2 CELLCARTA
    • 14.2.3 IREPERTOIRE, INC.
    • 14.2.4 NEW ENGLAND BIOLABS
    • 14.2.5 CERBA RESEARCH
    • 14.2.6 CEGAT GMBH
    • 14.2.7 ELEMENT BIOSCIENCES
    • 14.2.8 SEQALIS
    • 14.2.9 SYNBIO TECHNOLOGIES
    • 14.2.10 MEDGENOME
    • 14.2.11 ENPICOM

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 IMMUNE REPERTOIRE SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
  • TABLE 3 IMMUNE REPERTOIRE SEQUENCING MARKET: RISK ANALYSIS
  • TABLE 4 IMMUNE REPERTOIRE SEQUENCING MARKET: IMPACT ANALYSIS
  • TABLE 5 AVERAGE SELLING PRICE TREND OF IMMUNE REPERTOIRE SEQUENCING PRODUCTS, BY KEY PLAYER, 2022-2024 (USD)
  • TABLE 6 AVERAGE SELLING PRICE OF IMMUNE REPERTOIRE SEQUENCING INSTRUMENTS, BY REGION, 2024 (USD)
  • TABLE 7 IMMUNE REPERTOIRE SEQUENCING MARKET: PRODUCT PROVIDERS
  • TABLE 8 IMMUNE REPERTOIRE SEQUENCING MARKET: SERVICE PROVIDERS
  • TABLE 9 IMMUNE REPERTOIRE SEQUENCING MARKET: END USERS
  • TABLE 10 IMMUNE REPERTOIRE SEQUENCING MARKET: REGULATORY BODIES
  • TABLE 11 INNOVATIONS AND PATENT REGISTRATIONS, 2024-2025
  • TABLE 12 IMPORT DATA FOR HS CODE 3822, BY REGION, 2020-2024 (USD)
  • TABLE 13 EXPORT DATA FOR HS CODE 3822, BY REGION, 2020-2024 (USD)
  • TABLE 14 IMMUNE REPERTOIRE SEQUENCING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 IMMUNE REPERTOIRE SEQUENCING MARKET: PORTER'S FIVE FORCES
  • TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 21 KEY BUYING CRITERIA FOR MAJOR END USERS (PRODUCTS MARKET)
  • TABLE 22 KEY BUYING CRITERIA FOR MAJOR END USERS (SERVICES MARKET)
  • TABLE 23 IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 24 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 25 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 26 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 27 EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 31 TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 32 TCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 33 NORTH AMERICA: TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 EUROPE: TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 LATIN AMERICA: TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 MIDDLE EAST: TCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 38 HUMAN TCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 NORTH AMERICA: HUMAN TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 EUROPE: HUMAN TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: HUMAN TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 LATIN AMERICA: HUMAN TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 MIDDLE EAST: HUMAN TCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 MOUSE TCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 45 NORTH AMERICA: MOUSE TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 EUROPE: MOUSE TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: MOUSE TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 LATIN AMERICA: MOUSE TCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 MIDDLE EAST: MOUSE TCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 50 BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 51 BCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 NORTH AMERICA: BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 EUROPE: BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 LATIN AMERICA: BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 MIDDLE EAST: BCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 57 HUMAN BCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: HUMAN BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 EUROPE: HUMAN BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: HUMAN BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 LATIN AMERICA: HUMAN BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 MIDDLE EAST: HUMAN BCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 63 MOUSE BCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: MOUSE BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 EUROPE: MOUSE BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: MOUSE BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 LATIN AMERICA: MOUSE BCR KITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 MIDDLE EAST: MOUSE BCR KITS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 69 OTHER ASSAY KITS & REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: OTHER ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 EUROPE: OTHER ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: OTHER ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 73 LATIN AMERICA: OTHER ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 MIDDLE EAST: OTHER ASSAY KITS & REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 75 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 80 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 81 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 82 SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 83 SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 84 NORTH AMERICA: SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 EUROPE: SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 87 LATIN AMERICA: SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 88 MIDDLE EAST: SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 89 BULK SEQUENCING (MULTI-CELL SEQUENCING) TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 90 NORTH AMERICA: BULK SEQUENCING (MULTI-CELL SEQUENCING) TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: BULK SEQUENCING (MULTI-CELL SEQUENCING) TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: BULK SEQUENCING (MULTI-CELL SEQUENCING) TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 LATIN AMERICA: BULK SEQUENCING (MULTI-CELL SEQUENCING) TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 94 MIDDLE EAST: BULK SEQUENCING (MULTI-CELL SEQUENCING) TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 95 SINGLE-CELL SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 96 NORTH AMERICA: SINGLE-CELL SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 97 EUROPE: SINGLE-CELL SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: SINGLE-CELL SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 LATIN AMERICA: SINGLE-CELL SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 100 MIDDLE EAST: SINGLE-CELL SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 101 LIBRARY PREPARATION TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 102 NORTH AMERICA: LIBRARY PREPARATION TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 103 EUROPE: LIBRARY PREPARATION TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: LIBRARY PREPARATION TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 LATIN AMERICA: LIBRARY PREPARATION TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 MIDDLE EAST: LIBRARY PREPARATION TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 107 BIOINFORMATICS & DATA ANALYSIS TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 108 NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 109 EUROPE: BIOINFORMATICS & DATA ANALYSIS TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 111 LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 112 MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 113 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 114 SEQUENCING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 115 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 119 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 120 DATA ANALYSIS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 121 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 MIDDLE EAST: DATA ANALYSIS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 126 PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 127 NORTH AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 EUROPE: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 130 LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 132 IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 133 IMMUNE REPERTOIRE SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 134 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 135 EUROPE: IMMUNE REPERTOIRE SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 137 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 138 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 139 IMMUNE REPERTOIRE SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 140 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 141 EUROPE: IMMUNE REPERTOIRE SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 143 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 144 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 145 IMMUNE REPERTOIRE SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 146 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 147 EUROPE: IMMUNE REPERTOIRE SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 149 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 151 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 152 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 153 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 154 EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 156 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 157 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 158 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 159 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 160 EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 162 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 163 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 164 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 165 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 166 EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 168 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 169 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 170 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 171 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 172 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 173 EUROPE: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 175 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 176 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 177 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 178 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 179 EUROPE: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 181 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 182 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 183 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 184 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 185 EUROPE: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 187 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 188 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 189 IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 190 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 191 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 192 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 NORTH AMERICA: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 NORTH AMERICA: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 195 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 196 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 197 NORTH AMERICA: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 199 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 200 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 201 NORTH AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 202 US: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 203 US: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 US: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 205 US: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 US: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 207 US: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 208 US: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 US: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 210 US: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 211 US: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 212 CANADA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 213 CANADA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 214 CANADA: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 215 CANADA: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 216 CANADA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 217 CANADA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 218 CANADA: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 219 CANADA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 220 CANADA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 221 CANADA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 222 EUROPE: KEY MACROECONOMIC INDICATORS
  • TABLE 223 EUROPE: IMMUNE REPERTOIRE SEQUENCING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 224 EUROPE: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 225 EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 EUROPE: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 EUROPE: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 228 EUROPE: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 229 EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 230 EUROPE: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 EUROPE: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 232 EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 233 EUROPE: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 234 GERMANY: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 235 GERMANY: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 236 GERMANY: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 237 GERMANY: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 GERMANY: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 239 GERMANY: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 240 GERMANY: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 GERMANY: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 242 GERMANY: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 243 GERMANY: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 244 UK: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 245 UK: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 246 UK: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 247 UK: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 UK: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 249 UK: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 250 UK: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 251 UK: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 252 UK: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 253 UK: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 254 FRANCE: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 255 FRANCE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 FRANCE: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 FRANCE: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 258 FRANCE: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 259 FRANCE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 260 FRANCE: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 FRANCE: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 262 FRANCE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 263 FRANCE: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 264 ITALY: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 265 ITALY: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 266 ITALY: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 ITALY: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 268 ITALY: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 269 ITALY: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 270 ITALY: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 271 ITALY: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 272 ITALY: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 273 ITALY: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 274 SPAIN: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 275 SPAIN: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 276 SPAIN: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 277 SPAIN: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 278 SPAIN: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 279 SPAIN: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 280 SPAIN: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 281 SPAIN: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 282 SPAIN: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 283 SPAIN: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 284 REST OF EUROPE: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 285 REST OF EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 286 REST OF EUROPE: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 287 REST OF EUROPE: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 288 REST OF EUROPE: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 289 REST OF EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 290 REST OF EUROPE: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 291 REST OF EUROPE: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 292 REST OF EUROPE: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER,2023-2030 (USD MILLION)
  • TABLE 293 REST OF EUROPE: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 295 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 296 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 297 ASIA PACIFIC: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 298 ASIA PACIFIC: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 299 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 300 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 301 ASIA PACIFIC: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 302 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 303 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 304 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 305 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
  • TABLE 306 CHINA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 307 CHINA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 308 CHINA: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 309 CHINA: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 310 CHINA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 311 CHINA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 312 CHINA: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 313 CHINA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 314 CHINA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 315 CHINA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 316 JAPAN: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 317 JAPAN: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 318 JAPAN: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 319 JAPAN: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 320 JAPAN: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 321 JAPAN: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 322 JAPAN: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 323 JAPAN: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 324 JAPAN: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 325 JAPAN: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 326 INDIA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 327 INDIA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 328 INDIA: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 329 INDIA: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 330 INDIA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 331 INDIA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 332 INDIA: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 333 INDIA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 334 INDIA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 335 INDIA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 336 SOUTH KOREA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 337 SOUTH KOREA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 338 SOUTH KOREA: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 339 SOUTH KOREA: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 340 SOUTH KOREA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 341 SOUTH KOREA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 342 SOUTH KOREA: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 343 SOUTH KOREA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 344 SOUTH KOREA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 345 SOUTH KOREA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 346 AUSTRALIA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 347 AUSTRALIA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 348 AUSTRALIA: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 349 AUSTRALIA: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 350 AUSTRALIA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 351 AUSTRALIA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 352 AUSTRALIA: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 353 AUSTRALIA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 354 AUSTRALIA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 355 AUSTRALIA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 356 REST OF ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 357 REST OF ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 358 REST OF ASIA PACIFIC: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 359 REST OF ASIA PACIFIC: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 360 REST OF ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 361 REST OF ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 362 REST OF ASIA PACIFIC: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 363 REST OF ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 364 REST OF ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 365 REST OF ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 366 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 367 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 368 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 369 LATIN AMERICA: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 370 LATIN AMERICA: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 371 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 372 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 373 LATIN AMERICA: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 374 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 375 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 376 LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 377 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 378 BRAZIL: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 379 BRAZIL: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 380 BRAZIL: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 381 BRAZIL: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 382 BRAZIL: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 383 BRAZIL: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 384 BRAZIL: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 385 BRAZIL: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 386 BRAZIL: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 387 BRAZIL: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 388 MEXICO: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 389 MEXICO: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 390 MEXICO: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 391 MEXICO: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 392 MEXICO: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 393 MEXICO: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 394 MEXICO: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 395 MEXICO: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 396 MEXICO: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 397 MEXICO: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 398 REST OF LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 399 REST OF LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 400 REST OF LATIN AMERICA: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 401 REST OF LATIN AMERICA: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 402 REST OF LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 403 REST OF LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 404 REST OF LATIN AMERICA: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 405 REST OF LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 406 REST OF LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 407 REST OF LATIN AMERICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 408 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 409 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 410 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 411 MIDDLE EAST: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 412 MIDDLE EAST: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 413 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 414 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 415 MIDDLE EAST: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 416 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 417 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 418 MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 419 MIDDLE EAST: KEY MACROECONOMIC INDICATORS
  • TABLE 420 GCC COUNTRIES: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 421 GCC COUNTRIES: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 423 GCC COUNTRIES: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 424 GCC COUNTRIES: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 425 GCC COUNTRIES: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 426 GCC COUNTRIES: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 427 GCC COUNTRIES: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 428 GCC COUNTRIES: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 429 GCC COUNTRIES: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 430 REST OF MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 431 REST OF MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 432 REST OF MIDDLE EAST: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 433 REST OF MIDDLE EAST: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 434 REST OF MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 435 REST OF MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 436 REST OF MIDDLE EAST: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 437 REST OF MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 438 REST OF MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 439 REST OF MIDDLE EAST: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 440 AFRICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 441 AFRICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET FOR ASSAY KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 442 AFRICA: TCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 443 AFRICA: BCR KITS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 444 AFRICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 445 AFRICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 446 AFRICA: SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 447 AFRICA: IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 448 AFRICA: IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 449 AFRICA: IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 450 AFRICA: KEY MACROECONOMIC INDICATORS
  • TABLE 451 IMMUNE REPERTOIRE SEQUENCING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2022-2025
  • TABLE 452 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 453 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 454 IMMUNE REPERTOIRE SEQUENCING MARKET: REGION FOOTPRINT
  • TABLE 455 IMMUNE REPERTOIRE SEQUENCING MARKET: PRODUCT AND SERVICE FOOTPRINT
  • TABLE 456 IMMUNE REPERTOIRE SEQUENCING MARKET: APPLICATION FOOTPRINT
  • TABLE 457 IMMUNE REPERTOIRE SEQUENCING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 458 IMMUNE REPERTOIRE SEQUENCING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 459 IMMUNE REPERTOIRE SEQUENCING MARKET: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2022-MARCH 2025
  • TABLE 460 IMMUNE REPERTOIRE SEQUENCING MARKET: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 461 IMMUNE REPERTOIRE SEQUENCING MARKET: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 462 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 463 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 464 ILLUMINA, INC.: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2022-MARCH 2025
  • TABLE 465 ILLUMINA, INC.: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 466 ILLUMINA, INC.: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 467 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 468 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 469 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2022-MARCH 2025
  • TABLE 470 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 471 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 472 PACBIO: COMPANY OVERVIEW
  • TABLE 473 PACBIO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 474 PACBIO: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2022-MARCH 2025
  • TABLE 475 PACBIO: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 476 PACBIO: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 477 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
  • TABLE 478 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES/ SOLUTIONS OFFERED
  • TABLE 479 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2022-MARCH 2025
  • TABLE 480 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 481 10X GENOMICS: COMPANY OVERVIEW
  • TABLE 482 10X GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 483 10X GENOMICS: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2022-MARCH 2025
  • TABLE 484 QIAGEN: COMPANY OVERVIEW
  • TABLE 485 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 486 QIAGEN: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2022-MARCH 2025
  • TABLE 487 QIAGEN: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 488 QIAGEN: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 489 AGILENT TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 490 AGILENT TECHNOLOGIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 491 AGILENT TECHNOLOGIES: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 492 AGILENT TECHNOLOGIES: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 493 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 494 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 495 DANAHER CORPORATION: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 496 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 497 TAKARA BIO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 498 TAKARA BIO INC.: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 499 ADAPTIVE BIOTECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 500 ADAPTIVE BIOTECHNOLOGIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 501 BGI GROUP: COMPANY OVERVIEW
  • TABLE 502 BGI GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 503 BGI GROUP: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2022-MARCH 2025
  • TABLE 504 BGI GROUP: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 505 BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
  • TABLE 506 TECAN TRADING AG: COMPANY OVERVIEW
  • TABLE 507 TECAN TRADING AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 508 TECAN TRADING AG: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 509 AZENTA US INC.: COMPANY OVERVIEW
  • TABLE 510 AZENTA US INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 511 PERSONALIS, INC.: COMPANY OVERVIEW
  • TABLE 512 PERSONALIS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 513 PERSONALIS, INC.: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 514 PERSONALIS, INC.: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
  • TABLE 515 CREATIVE BIOLABS: COMPANY OVERVIEW
  • TABLE 516 CREATIVE BIOLABS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 517 CELEMICS, INC.: COMPANY OVERVIEW
  • TABLE 518 CELLCARTA: COMPANY OVERVIEW
  • TABLE 519 IREPERTOIRE, INC.: COMPANY OVERVIEW
  • TABLE 520 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 521 CERBA RESEARCH: COMPANY OVERVIEW
  • TABLE 522 CEGAT GMBH: COMPANY OVERVIEW
  • TABLE 523 ELEMENT BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 524 SEQALIS: COMPANY OVERVIEW
  • TABLE 525 SYNBIO TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 526 MEDGENOME: COMPANY OVERVIEW
  • TABLE 527 ENPICOM: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 IMMUNE REPERTOIRE SEQUENCING MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
  • FIGURE 2 IMMUNE REPERTOIRE SEQUENCING MARKET: YEARS CONSIDERED
  • FIGURE 3 IMMUNE REPERTOIRE SEQUENCING MARKET: RESEARCH DESIGN
  • FIGURE 4 IMMUNE REPERTOIRE SEQUENCING MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 5 IMMUNE REPERTOIRE SEQUENCING MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2024)
  • FIGURE 6 GLOBAL PRODUCTS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (2024)
  • FIGURE 7 GLOBAL SERVICES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (2024)
  • FIGURE 8 IMMUNE REPERTOIRE SEQUENCING MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 9 IMMUNE REPERTOIRE SEQUENCING MARKET: TOP-DOWN APPROACH
  • FIGURE 10 IMMUNE REPERTOIRE SEQUENCING MARKET: CAGR PROJECTIONS
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY WORKFLOW, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 IMMUNE REPERTOIRE SEQUENCING MARKET: REGIONAL SNAPSHOT
  • FIGURE 19 INCREASING ADOPTION OF PERSONALIZED MEDICINES AND RISING FOCUS ON GENOMIC RESEARCH TO DRIVE MARKET
  • FIGURE 20 US AND ASSAY KITS & REAGENTS DOMINATED NORTH AMERICAN MARKET IN 2024
  • FIGURE 21 SEQUENCING TECHNOLOGIES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2030
  • FIGURE 22 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO COMMAND LARGEST END USER MARKET SHARE IN 2025
  • FIGURE 23 CHINA TO REGISTER HIGHEST CAGR FROM 2025 TO 2030
  • FIGURE 24 IMMUNE REPERTOIRE SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 IMMUNE REPERTOIRE SEQUENCING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 26 AVERAGE SELLING PRICE OF IMMUNE REPERTOIRE SEQUENCING PRODUCTS, BY KEY PLAYER (2024)
  • FIGURE 27 AVERAGE SELLING PRICE OF IMMUNE REPERTOIRE SEQUENCING INSTRUMENTS, BY REGION, 2024 (USD)
  • FIGURE 28 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 IMMUNE REPERTOIRE SEQUENCING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 PATENT APPLICATIONS FOR IMMUNE REPERTOIRE SEQUENCING (JANUARY 2015-DECEMBER 2024)
  • FIGURE 32 IMMUNE REPERTOIRE SEQUENCING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 34 KEY BUYING CRITERIA FOR MAJOR END USERS (PRODUCTS MARKET)
  • FIGURE 35 KEY BUYING CRITERIA FOR MAJOR END USERS (SERVICES MARKET)
  • FIGURE 36 FUNDING AND NUMBER OF PROJECTS AND SUB-PROJECTS BY NATIONAL INSTITUTES OF HEALTH, 2021-2025
  • FIGURE 37 IMPACT OF AI/GEN AI ON IMMUNE REPERTOIRE SEQUENCING MARKET
  • FIGURE 38 NORTH AMERICA: IMMUNE REPERTOIRE SEQUENCING MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: IMMUNE REPERTOIRE SEQUENCING MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET (2022-2024)
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET (2022-2024)
  • FIGURE 42 MARKET SHARE ANALYSIS OF IMMUNE REPERTOIRE SEQUENCING PRODUCTS MARKET, 2024
  • FIGURE 43 MARKET SHARE ANALYSIS OF IMMUNE REPERTOIRE SEQUENCING SERVICES MARKET, 2024
  • FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 45 EV/EBITDA OF KEY PLAYERS
  • FIGURE 46 IMMUNE REPERTOIRE SEQUENCING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 47 IMMUNE REPERTOIRE SEQUENCING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 48 IMMUNE REPERTOIRE SEQUENCING MARKET: COMPANY FOOTPRINT
  • FIGURE 49 IMMUNE REPERTOIRE SEQUENCING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 50 ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 51 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 52 PACBIO: COMPANY SNAPSHOT
  • FIGURE 53 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT
  • FIGURE 54 10X GENOMICS: COMPANY SNAPSHOT
  • FIGURE 55 QIAGEN: COMPANY SNAPSHOT
  • FIGURE 56 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
  • FIGURE 57 DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 58 TAKARA BIO INC.: COMPANY SNAPSHOT
  • FIGURE 59 ADAPTIVE BIOTECHNOLOGIES: COMPANY SNAPSHOT
  • FIGURE 60 TECAN TRADING AG: COMPANY SNAPSHOT
  • FIGURE 61 AZENTA US INC.: COMPANY SNAPSHOT
  • FIGURE 62 PERSONALIS, INC.: COMPANY SNAPSHOT